Noah Auerhahn is Founder of Uncommon Therapeutics, which develops therapeutics for rare genetic diseases including Rett Syndrome.
Intro paths
YC
Noah went through Y Combinator (Winter 2025) — any YC alum in your network can reach them through the YC community.
GP
Their group partner at YC was Jared Friedman, General Partner at Y Combinator — the partner who ran Uncommon Therapeutics's batch and knows the company first-hand. YC profile ↗
→
In turn, Noah can intro founders to Uncommon Therapeutics's investors below.
Uncommon Therapeutics's investors · 2
Co-founders
Ryan Lim· Founder